menu
closed
ABOUT US
WE SEE NEW POSSIBILITIES TO RESPONSIBLY DEVELOP AND COMMERCIALIZE FIRST-IN-CLASS & BEST-IN-CLASS TREATMENTS WHERE OTHERS MAY NOT. ONCOZEN IS DEDICATED TO DISCOVER, DEVELOP AND COMMERCIALIZE NEXT-GENERATION NOVEL PHARMACEUTICAL AND BIOTECHNOLOGY PRODUCTS INCLUDING IN CLINICAL STAGE AS WELL AS PRECLINICAL STAGE THAT HAVE THE POTENTIAL TO ADDRESS A BROAD RANGE OF THERAPEUTIC EFFECTS WITH HIGH UNMET MEDICAL NEEDS.
By inventing, developing and commercializing these next-generation novel therapeutics, mission of ONCOZEN is to help patients extend their healthy and quality LIVES.
RELATIONSHIPS ARE VITAL TO THE SUCCESS OF OUR BUSINESS, AND WE ARE COMMITTED TO BE A TRUSTED PARTNER TO THE BIOPHARMACEUTICAL INDUSTRY.
COMPANY HISTORY
Walked footprints, a constant path of stubbornness and pride.
2024
2023
2022
2021
2020
LEADERSHIP
LEADERSHIP
We are a team of innovative and accomplished professionals with extensive experience in drug discovery,
development, and commercialization gained at leading biotechnology and pharmaceutical companies.
Leveraging our collective expertise and a broad industry network,
we excel at identifying and executing the optimal development pathway for each project,
ensuring the highest potential for success.
Advisory board
WOur Advisory Board is composed of professionals in
each various fields ranged from pre-clinical product development
to international commercial product for domestic and global market.
Based on powerful human network system,
we can more objectively evaluate potential
opportunities and can reach our goal successfully.
They will continue to play a critical role in improving
our team to be a global leading biopharmaceutical company
Joohoon Ahn, CEO
- · CEO, BIO GENETICS
- · CEO, Kyung Nam Pharm
- · Head, New Drug Division, Kwangdong Pharmaceutical
- · Current: Professor, College of Pharmacy, Jeonbuk National University
- · Current: Director, Efficacy Evaluation Center, Jeonbuk National University Hospital
- · Professor, Jeonbuk National Univ. College of Medicine
- · Ph.D. in Clinical Pharmacy, University of Florida
Hanjeong Chae, CTO
Ho Yoo, CSO
- · Director of Development, Kyung Nam Pharm
- · Team Leader, New Business Div., Kwangdong Pharmaceutical
- · R&D Planning Div., Chong Kun Dang Pharmaceutical
- · Researcher at Korea Institute of Science and Technology (KIST)
- · Executive Director, Kwangdong Pharmaceutical; Oncology Academic & Marketing
- · Clinical Instructor at KyungHee Medical Center
- · MD, Ph.D., KyungHee University College of Medicine
Donghoon Yang, VP
Isana Endo, BD Director
- · Over 22 years of professional business experience and track record of originating and executing deals in biotech startups and investment banks
Registration
With extensive experience in pharmaceutical and medical product development programs and regulatory requirements for Korea and global market, our qualified experts can provide advice from the early pre-IND stage of development to marketing application, therefore it can help us to plan and manage of our development of regulatory strategy more efficiently.
Based on know-how from currently practicing their fields such as state institution, research center, university for Bio-Technology and Medicinal Chemistry, qualified advisory team can support us to control well and get stringent quality spanning drug product development, analysis and clinical trail/ commercial material’s supply.
Technical
Preclinical
Organized Advisory Team is operated by scientists with decades of experience in their fields of specialization as Researcher, Ph.D., Assistant prof., Director etc. They implement effective and efficient approaches to help guide our research and development by providing a strong, reliable scientific foundation.
Based on experience over many decades and expertise with a broad range of study types, our board of portfolio can cover the role as advisor for best practices in study design and support us to overcome the challenges by maximizing efficiency and mitigating risk.
Clinical
Head Office
- Address3rd Floor, A-05, 194-25, Osongsaengmyeong 1-ro, Osong-eup, Cheongju-si, Chungcheongbuk-do, South Korea (Cheongju SB Plaza)
- E-MailOZ2020@oncozen.co.kr
R&D Center 1
- AddressC-713,724, Munjeong Hyundai Knowledge Industry Center, 7, Beobwon-ro 11-gil, Songpa-gu,Seoul
- E-MailOZ2020@oncozen.co.kr
R&D Center 2
- Address#302, College of Pharmacy, Jeonbuk National University, 20 Geonji-ro, Deokjin-gu, Jeonju-si, Jeollabuk-do, South Korea
- E-MailOZ2020@oncozen.co.kr